# ABACAVIR AND LAMIVUDINE
> **NDA208775** · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2017-04-06
## Drug
- **FDA Application Number:** NDA208775
- **Application type:** New Drug Application
- **Brand name:** ABACAVIR AND LAMIVUDINE
- **Generic name:** Abacavir
- **Active ingredients:** ABACAVIR; LAMIVUDINE
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2017-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208775)
---
*MORVS · CC0 1.0*